Neurobiological Technologies Inc - ESG Rating & Company Profile powered by AI
This webpage contains a questions and answers section about Neurobiological Technologies Inc. This ESG rating covers seventeen United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Decent Work & Economic Growth' and 'Peace, Justice & Strong Institutions'. Comprehensive Sustainability analysis of Neurobiological Technologies Inc are reached by logging in.
Neurobiological Technologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Neurobiological Technologies Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Neurobiological Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Does Neurobiological Technologies Inc disclose current and historical energy intensity?
Does Neurobiological Technologies Inc report the average age of the workforce?
Does Neurobiological Technologies Inc reference operational or capital allocation in relation to climate change?
Does Neurobiological Technologies Inc disclose its ethnicity pay gap?
Does Neurobiological Technologies Inc disclose cybersecurity risks?
Does Neurobiological Technologies Inc offer flexible work?
Does Neurobiological Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Neurobiological Technologies Inc disclose the number of employees in R&D functions?
Does Neurobiological Technologies Inc conduct supply chain audits?
Does Neurobiological Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Neurobiological Technologies Inc conduct 360 degree staff reviews?
Does Neurobiological Technologies Inc disclose the individual responsible for D&I?
Does Neurobiological Technologies Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Neurobiological Technologies Inc disclose current and / or historical scope 2 emissions?
Does Neurobiological Technologies Inc disclose water use targets?
Does Neurobiological Technologies Inc have careers partnerships with academic institutions?
Did Neurobiological Technologies Inc have a product recall in the last two years?
Does Neurobiological Technologies Inc disclose incidents of discrimination?
Does Neurobiological Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Has Neurobiological Technologies Inc issued a profit warning in the past 24 months?
Does Neurobiological Technologies Inc disclose parental leave metrics?
Does Neurobiological Technologies Inc disclose climate scenario or pathway analysis?
Does Neurobiological Technologies Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Neurobiological Technologies Inc disclose the pay ratio of women to men?
Does Neurobiological Technologies Inc support suppliers with sustainability related research and development?
Does Neurobiological Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Neurobiological Technologies Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Neurobiological Technologies Inc involved in embryonic stem cell research?
Does Neurobiological Technologies Inc disclose GHG and Air Emissions intensity?
Does Neurobiological Technologies Inc disclose its waste policy?
Does Neurobiological Technologies Inc report according to TCFD requirements?
Does Neurobiological Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Neurobiological Technologies Inc disclose energy use targets?
Does Neurobiological Technologies Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Neurobiological Technologies Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Neurobiological Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.